Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Infections in Hospitalised Patients with Multiple Myeloma: Main Characteristics and Risk Factors.

Valković T, Gačić V, Ivandić J, Petrov B, Dobrila-Dintinjana R, Dadić-Hero E, Načinović-Duletić A.

Turk J Haematol. 2015 Sep;32(3):234-42. doi: 10.4274/tjh.2013.0173.

2.

Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation.

Vallejo C, Batlle M, Vázquez L, Solano C, Sampol A, Duarte R, Hernández D, López J, Rovira M, Jiménez S, Valcárcel D, Belloch V, Jiménez M, Jarque I; Subcommittee of Non-Infectious Complications of the Grupo Español de Trasplante Hematopoyético (GETH).

Haematologica. 2014 Oct;99(10):1632-7. doi: 10.3324/haematol.2014.105908. Epub 2014 Jul 4.

3.

Accuracy of self-reported tobacco use status among hematopoietic SCT patients.

Ehlers SL, Bronars CA, Patten CA, Brockman T, Hughes C, Decker PA, Cerhan JR, Hogan W, Dispenzieri A, Ansell S, Ebbert J, Gastineau D.

Bone Marrow Transplant. 2014 Jul;49(7):961-5. doi: 10.1038/bmt.2014.70. Epub 2014 Apr 14.

4.

Pharmacogenetic study of deferasirox, an iron chelating agent.

Lee JW, Kang HJ, Choi JY, Kim NH, Jang MK, Yeo CW, Lee SS, Kim H, Park JD, Park KD, Shin HY, Shin JG, Ahn HS.

PLoS One. 2013 May 30;8(5):e64114. doi: 10.1371/journal.pone.0064114. Print 2013.

5.

An update on iron chelation therapy.

Poggiali E, Cassinerio E, Zanaboni L, Cappellini MD.

Blood Transfus. 2012 Oct;10(4):411-22. doi: 10.2450/2012.0008-12. Epub 2012 Jun 27. Review. No abstract available.

6.

Baseline platelet count and creatinine clearance rate predict the outcome of neutropenia-related invasive aspergillosis.

Nouér SA, Nucci M, Kumar NS, Grazziutti M, Restrepo A, Anaissie E.

Clin Infect Dis. 2012 Jun;54(12):e173-83. doi: 10.1093/cid/cis298. Epub 2012 Mar 15.

7.

Iron overload in patients undergoing hematopoietic stem cell transplantation.

Pullarkat V.

Adv Hematol. 2010;2010. pii: 345756. doi: 10.1155/2010/345756. Epub 2010 Sep 8.

8.

Increased serum iron levels and infectious complications after liver transplantation.

Chow JK, Werner BG, Ruthazer R, Snydman DR.

Clin Infect Dis. 2010 Aug 1;51(3):e16-23. doi: 10.1086/654802.

9.

The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia.

Ehlers SL, Gastineau DA, Patten CA, Decker PA, Rausch SM, Cerhan JR, Hogan WJ, Ebbert JO, Porrata LF.

Bone Marrow Transplant. 2011 Feb;46(2):285-90. doi: 10.1038/bmt.2010.113. Epub 2010 May 17.

10.

Fungal infections in transplant and oncology patients.

Person AK, Kontoyiannis DP, Alexander BD.

Infect Dis Clin North Am. 2010 Jun;24(2):439-59. doi: 10.1016/j.idc.2010.01.002. Review.

11.

Serum ferritin: Past, present and future.

Wang W, Knovich MA, Coffman LG, Torti FM, Torti SV.

Biochim Biophys Acta. 2010 Aug;1800(8):760-9. doi: 10.1016/j.bbagen.2010.03.011. Epub 2010 Mar 19. Review.

12.

Iron overload in hematologic malignancies and outcome of allogeneic hematopoietic stem cell transplantation.

Koreth J, Antin JH.

Haematologica. 2010 Mar;95(3):364-6. doi: 10.3324/haematol.2009.017244. No abstract available.

13.

Elevation of serum ferritin is associated with the outcome of patients with newly diagnosed multiple myeloma.

Song MK, Chung JS, Seol YM, Shin HJ, Choi YJ, Cho GJ.

Korean J Intern Med. 2009 Dec;24(4):368-73. doi: 10.3904/kjim.2009.24.4.368. Epub 2009 Nov 27.

14.

The transplant iron score as a predictor of stem cell transplant survival.

Storey JA, Connor RF, Lewis ZT, Hurd D, Pomper G, Keung YK, Grover M, Lovato J, Torti SV, Torti FM, Molnár I.

J Hematol Oncol. 2009 Oct 24;2:44. doi: 10.1186/1756-8722-2-44.

15.
16.

The iron chelator deferasirox protects mice from mucormycosis through iron starvation.

Ibrahim AS, Gebermariam T, Fu Y, Lin L, Husseiny MI, French SW, Schwartz J, Skory CD, Edwards JE Jr, Spellberg BJ.

J Clin Invest. 2007 Sep;117(9):2649-57.

17.

Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation.

Armand P, Kim HT, Cutler CS, Ho VT, Koreth J, Alyea EP, Soiffer RJ, Antin JH.

Blood. 2007 May 15;109(10):4586-8. Epub 2007 Jan 18.

Supplemental Content

Support Center